Understanding the molecular mechanisms of tumor dormancy and reactivation can facilitate the development of therapeutic strategies against metastatic recurrence (Giancotti 2013), comprising most of the ER+ breast cancer patient mortality (Goss & Chambers 2010). The gene discussed is ESR1; the disease is breast cancer.